Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 3:21 AM
Ignite Modification Date:
2025-12-26 @ 1:59 AM
NCT ID:
NCT03663205
Group ID:
EG000
Title:
Tislelizumab + Platinum + Pemetrexed
Description:
Tislelizumab 200 mg administered IV once every 3 weeks plus cisplatin 75 mg/m\^2 or carboplatin AUC 5 once every 3 weeks for 4 to 6 cycles and pemetrexed 500 mg/m\^2 once every 3 weeks until unacceptable toxicity or disease progression (each cycle is 21 days)
Deaths Number Affected:
144
Deaths Number At Risk:
None
Serious Number Affected:
99
Serious Number At Risk:
222
Other Number Affected:
222
Other Number At Risk:
222
Study:
NCT03663205
Results Section:
NCT03663205
Adverse Events Module:
NCT03663205